Normal Glypican-3 Serum Levels Do Not Eliminate the Risk of Hepatocellular Carcinoma

Normal Glypican-3 Serum Levels Do Not Eliminate the Risk of Hepatocellular Carcinoma

Introduction. Hepatocellular carcinoma (HCC) is a malignancy that primarily affects patients with liver cirrhosis. Early diagnosis is crucial for improving patient outcomes. The study aimed to investigate the potential role of glypican-3 (GPC3) serum levels, both alone and in combination with alp...

Full description

Bibliographic Details
Main Authors: Agnieszka Lembas, Tomasz Mikuła, Magdalena Suchacz, Joanna Kozłowska, Szymon Barczak, Barbara Badura, Alicja Wiercińska-Drapało
Format: Article
Language:English
Published: Ivano-Frankivsk National Medical University 2024-09-01
Series:Galician Medical Journal
Subjects:
hepatocellular carcinoma
glypican-3
biomarkers
Online Access:https://ifnmujournal.com/gmj/article/view/1965

Internet

https://ifnmujournal.com/gmj/article/view/1965

Similar Items